Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 2121, Suchdauer: 1.51s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Multidisciplinary discussion on phenotypical characterization of metastatic breast cancer and patient pathway optimization from an expert panel across South Italian regions

von Ardito, Raffaele ; Arpino, Grazia ; Caputo, Roberta ; et al.

Scientific Reports. 15(1)
- Zum Volltext in PubMed Central
Merkliste

2
Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models

von Formisano, Luigi ; Nappi, Lucia ; Rosa, Roberta ; et al.

Breast Cancer Research. 27(1)
- Zum Volltext in PubMed Central
Merkliste

3
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report

von Miglietta, Federica ; Razeti, Maria Grazia ; Caltavituro, Aldo ; et al.

In Critical Reviews in Oncology / Hematology September 2025 213
- View full text via DOI
Merkliste

4
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy

von Braybrooke, Jeremy ; Bradley, Rosie ; Hills, Robert K ; et al.

In The Lancet 9-15 August 2025 406(10503):603-614
- View full text via DOI
Merkliste

5
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review

von Zambelli, Alberto ; Cortesi, Laura ; Gaudio, Mariangela ; et al.

In Cancer Treatment Reviews November 2024 130
- View full text via DOI
Merkliste

6
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER)

von De Angelis, Carmine ; Pagliuca, Martina ; Magnolfi, Emanuela ; et al.

Schlagworte: HER2; chemo-free treatment; lapatinib; metastatic breast cancer
- View full text via BASE
Merkliste

7
COVID-19 in patients with thymic epithelial tumors with or without Good’s syndrome: a single-center retrospective study

von Pietroluongo, Erica ; Peddio, Annarita ; De Placido, Pietro ; et al.

BMC Cancer. 24(1)
- Zum Volltext in PubMed Central
Merkliste

8
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials

von Blondeaux, Eva ; Xie, Wanling ; Carmisciano, Luca ; et al.

In eClinicalMedicine April 2024 70
- View full text via DOI
Merkliste

9
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors

von Pietroluongo, Erica ; De Placido, Pietro ; Tortora, Marianna ; et al.

In Journal of Thoracic Oncology October 2023 18(10):1399-1407
- View full text via DOI
Merkliste

10
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread

von Criscitiello, Carmen ; Corti, Chiara ; De Laurentiis, Michelino ; et al.

In Cancer Treatment Reviews November 2023 120
- View full text via DOI
Merkliste

11
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

von Ascierto, Paolo A. ; Casula, Milena ; Bulgarelli, Jenny ; et al.

Nature Communications. 15(1)
- Zum Volltext in PubMed Central
Merkliste

12
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review

von Pietroluongo, Erica ; Luciano, Angelo ; Peddio, Annarita ; et al.
- View full text via BASE
Merkliste

13
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies

von Lambertini, Matteo ; Blondeaux, Eva ; Bisagni, Giancarlo ; et al.

In eClinicalMedicine May 2023 59
- View full text via DOI
Merkliste

14
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer

von Schettini, Francesco ; Venturini, Sergio ; Giuliano, Mario ; et al.

In Cancer Treatment Reviews December 2022 111
- View full text via DOI
Merkliste

15
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

von Balic, Marija ; Heibl, Sonja ; Zabernigg, August Felix ; et al.

In ESMO Open February 2023 8(1)
- View full text via DOI
Merkliste

16
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study

von Procopio, Giuseppe ; Chiuri, Vincenzo ; Mantini, Giovanna ; et al.

In ESMO Open April 2022 7(2)
- View full text via DOI
Merkliste

17
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review

von Servetto, Alberto ; Salomone, Fabio ; Di Costanzo, Fabrizio ; et al.

In Critical Reviews in Oncology / Hematology April 2022 172
- View full text via DOI
Merkliste

18
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial

von Basile, Debora ; Rosati, Gerardo ; Bergamo, Francesca ; et al.

In Clinical Colorectal Cancer June 2023 22(2):190-198
- View full text via DOI
Merkliste

19
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study

von Marina Elena Cazzaniga ; Paolo Pronzato ; Domenico Amoroso ; et al.
- View full text via BASE
Merkliste

20
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide

von Di Lorenzo, Giuseppe ; Zappavigna, Silvia ; Crocetto, Felice ; et al.

In Clinical Genitourinary Cancer October 2021 19(5):e286-e298
- View full text via DOI
Merkliste

21
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

von Bradley, Rosie ; Braybrooke, Jeremy ; Gray, Richard ; et al.

In The Lancet Oncology March 2022 23(3):382-392
- View full text via DOI
Merkliste

22
Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions

von Generali, Daniele ; Berardi, Rossana ; Caruso, Michele ; et al.

Schlagworte: aromatase inhibitor; bone lo; breast cancer; cardiotoxicity; drug adherence
- View full text via BASE
Merkliste

23
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer

von Servetto, Alberto ; Napolitano, Fabiana ; De Angelis, Carmine ; et al.

In Critical Reviews in Oncology / Hematology January 2021 157
- View full text via DOI
Merkliste

24
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma

von Ascierto, Paolo A. ; Mandalà, Mario ; Ferrucci, Pier Francesco ; et al.

Schlagworte: Melanoma; BRAF/MEK inhibitors; sequencing
- View full text via BASE
Merkliste

25
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

von Timcheva, Constanta ; Tomova, Antoaneta ; Eisen, Andrea ; et al.

In European Journal of Cancer July 2021 152:68-77
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag